Stem cells and cancer cells have enough molecular similarities that the former can be used to trigger immunity against the latter.
The Scientist is bringing together a panel of experts to share their research, discuss current therapeutic approaches, and to offer their insights.
January 3, 2018|
Wednesday, April 11, 2018
2:30-4:00 PM Eastern Time
Various neurodegenerative processes result in the development of diseases like Alzheimer’s (AD), Parkinson’s (PD), amyotrophic lateral sclerosis (ALS), and, arguably, multiple sclerosis (MS). Despite years of research, drug discovery initiatives, and promising clinical trials, these diseases remain incurable. But recent studies have suggested common mechanisms underlying these pathologies. Atypical protein assembly resulting in plaque formation is a common pathological finding in both AD and PD, while neuronal death is a primary (ALS) or secondary (MS) hallmark of disease. For a detailed look at the mechanisms that drive an array of neurodegenerative diseases, The Scientist is bringing together a panel of experts to share their research, discuss current therapeutic approaches, and offer their insights. Come engage with our panel and get the answers you seek.
Topics to be covered:
Rudolph E. Tanzi, PhD
Joseph. P. and Rose F. Kennedy Professor of Neurology
Harvard Medical School
Vice-Chair, Department of Neurology; Director, Genetics and Aging Research Unit
Massachusetts General Hospital
Gregory A. Petsko, DPhil
Mahon Professor, Department of Neurology and Neuroscience
Director, Appel Alzheimer’s Disease Research Institute
Weill Cornell Medicine